Table 2: Medication used in the investigated collective of diabetic patients with and without cardiovascular complications (CVCs).
Medication | Patients without CVCs (n = 32) | Patients with CVCs (n = 28) | p* | ||
---|---|---|---|---|---|
n | % | n | % | ||
Metformin | 24 | 75 | 19 | 67.9 | 0.05 |
DPP4 Inhibitors or Incretine mimetica | 12 | 37.5 | 9 | 32.1 | 0.498 |
Sulfonylureas | 4 | 12.5 | 6 | 21.4 | 0.49 |
Insulin | 14 | 43.8 | 19 | 67.8 | 0.07 |
Statins | 14 | 43.8 | 23 | 82.1 | 0.01 |
Diuretics | 16 | 50 | 18 | 64.3 | 0.27 |
Beta Blockers | 15 | 46.9 | 20 | 71.4 | 0.05 |
Calcium antagonists | 12 | 37.5 | 9 | 32.1 | 0.49 |
ACE-Inhibitors or AT1-Blockers | 26 | 81.3 | 26 | 92.8 | 0.26 |
*bold denotes p < 0.05.